Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical lidocaine for pain relief during superficial burn debridement
IRCT20260725070352N1Phase 3Recruiting
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of lidocaine in burn injury (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Pain severity at 6 hours. Started Oct 2026; status: recruiting.
02
Drugs
lidocaine
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20260725070352N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260725070352N1.